Valuation: Medios AG

Market Cap 305M 348M 281M 261M 495M 33.2B 502M 3.36B 1.31B 16.3B 1.31B 1.28B 56.51B P/E 2026 *
11.3x
P/E 2027 * 8.91x
Enterprise Value 381M 435M 351M 326M 619M 41.5B 627M 4.2B 1.63B 20.37B 1.63B 1.6B 70.62B EV / Sales 2026 *
0.18x
EV / Sales 2027 * 0.16x
Free-Float
92.4%
Yield 2026 *
-
Yield 2027 * -
1 day-1.13%
1 week+2.32%
Current month+2.32%
1 month-0.32%
6 months-18.90%
Current year-14.64%
1 week 11.8
Extreme 11.8
13
1 month 11.8
Extreme 11.8
13
Current year 11.64
Extreme 11.64
17.44
1 year 11.64
Extreme 11.64
17.44
3 years 9.98
Extreme 9.98
18.5
5 years 9.98
Extreme 9.98
41.6
10 years 7.41
Extreme 7.41
42
Manager TitleAgeSince
Chief Executive Officer 58 01/02/2026
Director of Finance/CFO 54 15/04/2026
Investor Relations Contact - -
Director TitleAgeSince
Chairman 53 07/11/2014
Director/Board Member 65 14/09/2016
Director/Board Member 57 10/06/2021
Date Insider Type Main position Quantity % Market Cap.
02-04Sell

Chief Executive Officer

13,638 0.0535%
01-22Buy

Executive/Senior Manager

4,000 0.0157%
19/08/24Buy

Executive/Senior Manager

10,000 0.0392%
Change 5-day change 1-year change 3-year change Capi.($)
-1.13%+2.32%-4.92%-25.36% 348M
-1.14%-2.43%+53.72%+159.07% 1,070B
-1.41%+0.32%+66.23%+60.48% 624B
-2.42%+0.18%+34.59%+85.62% 450B
-2.01%+0.53%+31.00%+25.82% 328B
+0.48%+0.41%+38.56%+40.04% 292B
+0.02%-1.12%+28.22%+47.40% 284B
+1.77%+3.75%-26.02%-39.22% 217B
-2.06%+1.63%+22.87%+64.34% 198B
-1.26%+2.60%+15.98%+70.00% 161B
Average -0.91%+1.23%+26.02%+48.82% 362.47B
Weighted average by Cap. -1.08%+0.77%+40.08%+81.56%

Financials

2026 *2027 *
Net sales 2.08B 2.38B 1.92B 1.78B 3.38B 227B 3.42B 22.95B 8.93B 111B 8.93B 8.73B 386B 2.14B 2.44B 1.97B 1.83B 3.47B 233B 3.52B 23.57B 9.17B 114B 9.17B 8.97B 396B
Net income 27.41M 31.29M 25.24M 23.43M 44.49M 2.98B 45.1M 302M 118M 1.47B 118M 115M 5.08B 34.51M 39.4M 31.78M 29.5M 56.02M 3.76B 56.78M 380M 148M 1.84B 148M 145M 6.4B
Net Debt 76.15M 86.95M 70.14M 65.11M 124M 8.29B 125M 840M 327M 4.07B 327M 319M 14.12B 40.72M 46.5M 37.51M 34.82M 66.12M 4.44B 67.01M 449M 175M 2.18B 175M 171M 7.55B
Logo Medios AG
Medios AG, formerly Crevalis Capital AG, is a Germany-based company offering solutions in pharma industry. The Company covers relevant aspects of supply chain like from pharmaceutical supply and manufacture of patient-specific therapies, including blistering and others. It operates in two segments Pharmaceutical supply which focuses on pharmaceutical wholesale with finished specialty pharma (high-priced drugs for rare and chronic diseases) medications including oncology, neurology, autoimmunology, ophthalmology, infectiology, hemophilia along with offering finished medicinal products; Patient-specific therapies focusing on pharmaceutical manufacturing of patient-specific preparations such as Cytostatic infusions, Antibody therapies, Virostatic and antibiotic medications, Parenteral nutrition solutions, Investigational medicinal products are among others. Its products and services include Patient health & protection and procedures & processes for patient care and digitalization of data.
Employees
993
Date Price Change Volume
07/07/26 12.36 -0.64% 872
06/07/26 €12.44 +0.16% 29,760
03/07/26 €12.42 +1.47% 10,480
02/07/26 €12.24 +0.99% 12,984
01/07/26 €12.12 +0.33% 20,361
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
12.44EUR
Average target price
23.00EUR
Spread / Average Target
+84.89%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILM1 Stock